These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 38674860)

  • 1. Supplementation of Silymarin Alone or in Combination with Salvianolic Acids B and Puerarin Regulates Gut Microbiota and Its Metabolism to Improve High-Fat Diet-Induced NAFLD in Mice.
    Wang X; Jin Y; Di C; Zeng Y; Zhou Y; Chen Y; Pan Z; Li Z; Ling W
    Nutrients; 2024 Apr; 16(8):. PubMed ID: 38674860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice.
    Matsui M; Fukunishi S; Nakano T; Ueno T; Higuchi K; Asai A
    mBio; 2021 Aug; 12(4):e0115521. PubMed ID: 34225483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penthorum chinense Pursh. extract attenuates non-alcholic fatty liver disease by regulating gut microbiota and bile acid metabolism in mice.
    Li X; Zhao W; Xiao M; Yu L; Chen Q; Hu X; Zhao Y; Xiong L; Chen X; Wang X; Ba Y; Guo Q; Wu X
    J Ethnopharmacol; 2022 Aug; 294():115333. PubMed ID: 35500802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatobiliary and pancreatic: Multi-donor fecal microbiota transplantation attenuated high-fat diet-induced hepatic steatosis in mice by remodeling the gut microbiota.
    Shou D; Luo Q; Tang W; Cao C; Huang H; Chen H; Zhou Y
    J Gastroenterol Hepatol; 2023 Dec; 38(12):2195-2205. PubMed ID: 37787118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ling-Gui-Zhu-Gan decoction ameliorates nonalcoholic fatty liver disease via modulating the gut microbiota.
    Chen L-p; Zhang L-f; Liu S; Hua H; Zhang L; Liu B-c; Wang R-r
    Microbiol Spectr; 2024 Jun; 12(6):e0197923. PubMed ID: 38647315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Ilex hainanensis Merr. On HFD-induced nonalcoholic fatty liver disease and rebalance of gut microbiota and bile acids metabolism in mice.
    Tian JY; Xiao M; Zhao WW; Wu X; Yang J; Chen XQ
    Fitoterapia; 2024 Oct; 178():106186. PubMed ID: 39142527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitigation of high-fat diet-induced hepatic steatosis by thyme (
    Sheng X; Zhan P; Wang P; He W; Tian H
    Food Funct; 2024 Jul; 15(14):7333-7347. PubMed ID: 38305590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the fecal microbiome and metabolome by resistant dextrin ameliorates hepatic steatosis and mitochondrial abnormalities in mice.
    Zhang Z; Chen X; Cui B
    Food Funct; 2021 May; 12(10):4504-4518. PubMed ID: 33885128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Network Involving Gut Microbiota, Circulating Bile Acids, and Hepatic Metabolism Genes That Protects Against Non-Alcoholic Fatty Liver Disease.
    Petrov PD; García-Mediavilla MV; Guzmán C; Porras D; Nistal E; Martínez-Flórez S; Castell JV; González-Gallego J; Sánchez-Campos S; Jover R
    Mol Nutr Food Res; 2019 Oct; 63(20):e1900487. PubMed ID: 31322321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coffee prevents fatty liver disease induced by a high-fat diet by modulating pathways of the gut-liver axis.
    Vitaglione P; Mazzone G; Lembo V; D'Argenio G; Rossi A; Guido M; Savoia M; Salomone F; Mennella I; De Filippis F; Ercolini D; Caporaso N; Morisco F
    J Nutr Sci; 2019; 8():e15. PubMed ID: 31037218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis.
    Wang P; Wang J; Li D; Ke W; Chen F; Hu X
    J Nutr Biochem; 2020 Jul; 81():108363. PubMed ID: 32388250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pure total flavonoids from citrus attenuate non-alcoholic steatohepatitis via regulating the gut microbiota and bile acid metabolism in mice.
    He B; Jiang J; Shi Z; Wu L; Yan J; Chen Z; Luo M; Cui D; Xu S; Yan M; Zhang S; Chen Z
    Biomed Pharmacother; 2021 Mar; 135():111183. PubMed ID: 33401222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary bile acids supplementation improves the growth performance and alleviates fatty liver in broilers fed a high-fat diet via improving the gut microbiota.
    Hu D; Hou M; Song P; Chen Q; Feng Y; Wu X; Ni Y
    Poult Sci; 2024 Feb; 103(2):103270. PubMed ID: 38056054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Hesperidin Supplementation on Liver Metabolomics and Gut Microbiota in a High-Fat Diet-Induced NAFLD Mice Model.
    Li X; Yao Y; Wang Y; Hua L; Wu M; Chen F; Deng ZY; Luo T
    J Agric Food Chem; 2022 Sep; 70(36):11224-11235. PubMed ID: 36048007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiomics reveals the ameliorating effect and underlying mechanism of aqueous extracts of polygonatum sibiricum rhizome on obesity and liver fat accumulation in high-fat diet-fed mice.
    Ou X; Chen J; Li B; Yang Y; Liu X; Xu Z; Xiang X; Wang Q
    Phytomedicine; 2024 Sep; 132():155843. PubMed ID: 38971026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota of miR-30a-5p-deleted mice aggravate high-fat diet-induced hepatic steatosis by regulating arachidonic acid metabolic pathway.
    Wang R; Zhang X; Wang Y; Lin Y; Zhou Y; Wang Y; Li G
    Clin Transl Med; 2024 Oct; 14(10):e70035. PubMed ID: 39360667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lingguizhugan decoction attenuates diet-induced obesity and hepatosteatosis
    Liu MT; Huang YJ; Zhang TY; Tan LB; Lu XF; Qin J
    World J Gastroenterol; 2019 Jul; 25(27):3590-3606. PubMed ID: 31367159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A botanical dietary supplement from white peony and licorice attenuates nonalcoholic fatty liver disease by modulating gut microbiota and reducing inflammation.
    Chen L; Kan J; Zheng N; Li B; Hong Y; Yan J; Tao X; Wu G; Ma J; Zhu W; Sheng L; Chen L; Li B; Zhong J; Du J; Li H
    Phytomedicine; 2021 Oct; 91():153693. PubMed ID: 34403877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tangshen formula targets the gut microbiota to treat non-alcoholic fatty liver disease in HFD mice: A 16S rRNA and non-targeted metabolomics analyses.
    Wang S; Li X; Zhang B; Li Y; Chen K; Qi H; Gao M; Rong J; Liu L; Wan Y; Dong X; Yan M; Ma L; Li P; Zhao T
    Biomed Pharmacother; 2024 Apr; 173():116405. PubMed ID: 38484559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal Betaine Supplementation Mitigates Maternal High Fat Diet-Induced NAFLD in Offspring Mice through Gut Microbiota.
    Sun L; Tan X; Liang X; Chen H; Ou Q; Wu Q; Yu X; Zhao H; Huang Q; Yi Z; Wei J; Wu F; Zhu H; Wang L
    Nutrients; 2023 Jan; 15(2):. PubMed ID: 36678155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.